Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Hangzhou Tigermed Consulting Co., Ltd. Class H ( (HK:3347) ) has issued an update.
Hangzhou Tigermed Consulting Co., Ltd. released its first quarterly report for 2025, highlighting that the financial statements were prepared according to the China Accounting Standards for Business Enterprises and remain unaudited. The report serves as a disclosure in compliance with Hong Kong’s listing rules, providing stakeholders with essential financial information.
More about Hangzhou Tigermed Consulting Co., Ltd. Class H
Hangzhou Tigermed Consulting Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, primarily operating in the consulting industry. The company, along with its subsidiaries, focuses on providing comprehensive consulting services.
YTD Price Performance: -18.58%
Average Trading Volume: 121
Technical Sentiment Signal: Buy
Current Market Cap: €3.97B
See more data about 3347 stock on TipRanks’ Stock Analysis page.